Video summary

High Demand IPO: Competitor లేని Aerospace Stock INDO-MIM IPO — Apply OR Avoid?

Main summary

Key takeaways

Finance

Finance-focused summary (Indo-AIM / Indo-MIM IPO)

Company & technology positioning

  • The company (IndoAIM / Indo-MIM) uses EAIM / MIM (metal injection molding) technology to manufacture small, complex aerospace/defense components.
  • Claimed differentiation: “No other listed company in India” uses this EAIM technology; internationally, only one Chinese company is mentioned as using similar technology.
  • Technology-related scope expansion (to support growth):
    • Precision machining
    • Ceramic injection casting
    • Investment moldings
    • 3D printing-related technologies
  • Manufacturing/scale claims:
    • Global market share: 6.8%
    • Exports to 55 countries
    • 15 manufacturing facilities: 6 India, 6 US, plus UK and Mexico (exact UK/Mexico split appears unclear)

Industry & revenue mix (growth drivers / concentration)

  • Automotive: 24% (fuel systems, powertrains, interior applications)
  • Defense: 18.69% (triggers, hammers); defense client relationships claimed to last 17 years
  • Medical: 18.08%
  • Consumer: 10.8% (e.g., cell phone components)
  • Aerospace (15.86%)
    • Aerospace parts mentioned include: nozzle locking, servo motor housing adapters, precision housing, etc.

Customer economics / international exposure

  • International revenue dominance (FY26):
    • 77.2% international vs 22.8% India
    • North America: 43%
    • Europe: 19%
    • Southeast Asia: 2.65%
    • Rest of world: 10.9%
  • Client base & repeat customers:
    • Client base: 1100
    • Repeat customer %: 79.64%
    • Claim: 91.6% of total revenue from repeat customers
    • “Financial mention” claim: 308 new clients in 26 days
  • Raw material sourcing:
    • 40% from India, 60% international
  • Workforce: 4,424 employees (at filing, RHP)

IPO details & key investment/tail risk flags

IPO structure

  • Issue size: ₹381 crore
  • Company receives: ₹499 crore (subtitle appears inconsistent with arithmetic; likely mis-phrased)
  • OFS portion: ₹3,312 crore
    • Implication: most proceeds go to selling shareholders, not the company.
  • Risk disclosure (explicit): “Remember this”
    • Higher OFS means subscribers are effectively funding existing shareholders, not capitalizing business growth.

Pricing / valuation

  • Price band: ₹461 to ₹485 per share
  • At higher end, implied market cap: ₹23,981 crore
  • Subscription guidance: “participate in a multiple of 30 shares” (lot size constraint)

Timeline

  • IPO opens: 23rd
  • IPO closes: 27th (month not specified)

Allotment priority mentioned

  • Split mentioned as 50% / 15% / 35%, but category labels appear garbled and are not reliably readable.

Recommendation-style caution

  • Potential demand drivers:
    • Emphasis on uniqueness/“entry barriers” (described as “worth studying / worth putting on a watch list”)
  • Main IPO-specific risk:
    • “OFS is on the higher side”
  • Practical note (channel disclaimer context):
    • Suggestion to use multiple family members’ Demat accounts if applying via family accounts

Financial performance metrics (historical)

Balance sheet / leverage

  • Debt: ₹1,090 crore
  • Management indicated that majority of IPO-raised capital is for debt clearance
  • Debt-to-equity: 0.338 (described as within a “comfortable” range)

Revenue & profitability growth

  • Revenue CAGR (last three years): 20.86%
  • Operating EBITDA growth: 20.02%
  • Margins:
    • “Consistently maintaining” ~25% margin (context suggests EBITDA margin, though the subtitle isn’t explicit)
  • PAT growth: 37% CAGR (last three years)
  • PAT margin: approximately 12%
  • Cash flow: positive cash flow from operations

Peer/valuation comparisons (method discussed implicitly)

Technology peer (China)

  • Peer named: Jiangsu Gain Technology (Chinese company)
  • Margin comparison:
    • Reported margins for Chinese peer: 15.2%, 11%, with “volatility”
  • Valuation comparison:
    • Chinese company trading at a “slightly higher valuation” than IndoAIM (exact multiples not clearly stated)

Indian “aerospace/auto suppliers” peer set

  • Valuation multiples mentioned:
    • Company valuation: ~44.62x (subtitle says “price chain”; likely P/E)
    • ~22.97x EV/EBITDA
  • Statement: other Indian listed players reportedly trading at “almost similar valuations”
  • Return metrics: 21.26% (IRR/ROE?) and 26.6% ROC of 6% (subtitle unclear on metric definitions/order)

Methodology / framework mentioned (explicit steps)

Due diligence / homework approach

  • Read differences between EAIM vs diecasting technology (via news/Google)

IPO evaluation checkpoints (implicit framework)

  • Uniqueness/technology defensibility (gap vs listed competitors)
  • Revenue mix by end-market (auto/defense/medical/consumer/aerospace)
  • Geography split (India vs North America/Europe exposure)
  • Customer concentration/retention (repeat customers, multi-year relationships)
  • Balance-sheet risk (debt level, debt/equity)
  • Growth metrics (revenue, EBITDA, PAT)
  • Margin stability
  • IPO structure risk: OFS share vs fresh capital
  • Valuation vs peers (P/E or similar and EV/EBITDA multiples)

Instruments / tickers mentioned

  • No specific stock/ETF/crypto/bond tickers are explicitly listed.
  • Company: IndoAIM / Indo-MIM
  • Peer company: Jiangsu Gain Technology (China; no ticker provided)

Key numerical takeaways (as stated)

  • Global MIM/EAIM market share: 6.8%
  • Facilities: 15 (India 6, US 6, plus UK and Mexico)
  • Export countries: 55
  • Revenue mix: 24% auto, 18.69% defense, 18.08% medical, 10.8% consumer, 15.86% aerospace
  • FY26 geography: 22.8% India / 77.2% international
    • North America 43%, Europe 19%
  • Clients: 1100
    • Repeat customers: 79.64%
    • 91.6% of revenue from repeat customers
  • Raw materials: 40% India / 60% international
  • Employees: 4,424
  • Promoters’ stake (as of filing context):
    • 92.44% at RHP filing
    • Reduced to 65% post listing (due to OFS and SEBI offload rules)
  • IPO pricing: ₹461–₹485
  • Market cap (implied at higher price): ₹23,981 crore
  • IPO dates: opens 23rd, closes 27th
  • Debt: ₹1,090 crore
  • Debt-to-equity: 0.338
  • Growth: revenue 20.86%, EBITDA 20.02%, PAT 37%
  • Margins: “~25%” (described), PAT margin ~12%
  • Valuation: ~44.62x (likely P/E) and ~22.97x EV/EBITDA
  • Main IPO risk flagged: OFS is “on the higher side”

Presenters / sources mentioned

  • Presenter: Sai Krishna Patri
  • Company management (as stated):
    • Senior Krishna Chaukula (Chairman & MD)
    • Junior Krishna Chaukala (CEO)
    • B. Balasubramanian (CFO)
  • Source/institution mentioned: IIT Madras
  • Technology peer/company mentioned: Jiangsu Gain Technology

Original video